These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2683591)

  • 21. [The tryptophan depletion test. Basic principles and clinical relevance].
    Neumeister A; Praschak-Rieder N; Hesselmann B; Tauscher J; Kasper S
    Nervenarzt; 1997 Jul; 68(7):556-62. PubMed ID: 9333716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1984 Apr; 41(4):398-402. PubMed ID: 6703856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The serotonin hypothesis of depression].
    Lesch KP; Beckmann H
    Fortschr Neurol Psychiatr; 1990 Nov; 58(11):427-38. PubMed ID: 2177721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the 5-HT neurotransmission by antidepressant treatments.
    De Montigny C
    J Physiol (Paris); 1981; 77(2-3):455-61. PubMed ID: 6270317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.
    Cowen PJ; McCance SL; Cohen PR; Julier DL
    Psychopharmacology (Berl); 1989; 99(2):230-2. PubMed ID: 2508159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine markers of serotonin responsivity in depression.
    Stahl SM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Sep; 16(5):655-9. PubMed ID: 1496123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior.
    Mann JJ
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):99S-105S. PubMed ID: 10432495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders.
    Csernansky JG; Sheline YI
    Ann Clin Psychiatry; 1993 Dec; 5(4):275-81. PubMed ID: 8312985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects.
    Mahar I; Bambico FR; Mechawar N; Nobrega JN
    Neurosci Biobehav Rev; 2014 Jan; 38():173-92. PubMed ID: 24300695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin 5-HT(2A) receptor gene polymorphism, 5-HT(2A) receptor function and personality traits in healthy subjects: a negative study.
    Kusumi I; Suzuki K; Sasaki Y; Kameda K; Sasaki T; Koyama T
    J Affect Disord; 2002 Apr; 68(2-3):235-41. PubMed ID: 12063151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
    Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eating disorders and depression: is there a serotonin connection?
    Jimerson DC; Lesem MD; Kaye WH; Hegg AP; Brewerton TD
    Biol Psychiatry; 1990 Sep; 28(5):443-54. PubMed ID: 2207221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serotonin in therapy of depression and related disorders.
    Fuller RW
    J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral serotonergic receptor sensitivity in depressive illness.
    Wood K; Swade C; Abou-Saleh M; Coppen A
    J Affect Disord; 1984 Aug; 7(1):59-65. PubMed ID: 6236244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proserotoninergic agents and depression (author's transl)].
    Uzan A
    Encephale; 1982; 8(2):273-89. PubMed ID: 6286277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotonin receptor changes in depression: evidences and limitations].
    Gómez E; Catalán R; Navinés R; Gastó C
    Actas Esp Psiquiatr; 2001; 29(3):186-94. PubMed ID: 11412493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ; McCance SL; Ware CJ; Cohen PR; Chalmers JS; Julier DL
    Br J Psychiatry; 1991 Sep; 159():341-6. PubMed ID: 1659918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ
    Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.